S-Space

Browse

Author

Showing results 1 to 2 of 2

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2021-01	A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer Schmid, Peter; Sablin, Marie-Paule; Bergh, Jonas; Im, Seock-Ah; Lu, Yen-Shen; Martinez, Noelia; Neven, Patrick; Lee, Keun Seok; Morales, Serafin; Perez-Fidalgo, J. Alejandro; Adamson, Douglas; Goncalves, Anthony; Prat, Aleix; Jerusalem, Guy; Schlieker, Laura; Espadero, Rosa-Maria; Bogenrieder, Thomas; Huang, Dennis Chin-Lun; Crown, John; Cortes, Javier Breast Cancer Research, Vol.23 No.1	DOI
2021-01	A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer Schmid, Peter; Sablin, Marie-Paule; Bergh, Jonas; Im, Seock-Ah; Lu, Yen-Shen; Martínez, Noelia; Neven, Patrick; Lee, Keun Seok; Morales, Serafín; Pérez-Fidalgo, J. A; Adamson, Douglas; Gonçalves, Anthony; Prat, Aleix; Jerusalem, Guy; Schlieker, Laura; Espadero, Rosa-Maria; Bogenrieder, Thomas; Huang, Dennis C; Crown, John; Cortés, Javier Breast Cancer Research. 2021 Jan 15;23(1):8	view file DOI